Back to
Kestra Advisory Services, LLC
CORT
Showing 9 of 13 quarters
Position history for
Kestra Advisory Services, LLC's holdings in Corcept Therapeutics Incorporated
Yes. Kestra Advisory Services holds 8,170 shares of CORT (Corcept Therapeutics), worth $941,429, as of its Q3 2026 13F filing. It reduced the position by 2,744 shares (-25.1%) from Q2 2026. Kestra Advisory Services has held CORT since Q2 2026, across 2 quarterly 13F filings.
Current Value
$941,429
Current Shares
8,170
Total Value Change
+$548,697
Total Shares Change
-316
Quarter-by-Quarter History